Relay Therapeutics, Inc.

NASDAQ:RLAY

6.16 (USD) • At close November 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -88.105-92.212-81.387-83.495-65.734-98.505-94.239-67.503-84.172-76.788-62.046-67.456-60.834-193.398-42.18435.276-36.078-26.724-24.886-23.913-19.673-17.537-14.182
Depreciation & Amortization -8.7671.3681.3951.3751.3631.3341.1971.1661.0330.9560.9751.0341.0120.960.9190.9120.9130.8650.8590.8530.6340.6910.667
Deferred Income Tax 0005.077-2.876-2.201000000.6810.67-0.001000000000
Stock Based Compensation 22.48426.83227.18819.26721.83523.41121.51813.81713.71915.14713.45510.21812.41816.1479.67114.54411.9294.0321.4551.3061.2481.0820.82
Change In Working Capital -20.82212.8447.978-20.599-28.7859.5127.4146.37-0.3272.8462.35714.98-8.46512.74878.081-86.018-0.8111.10.559-0.3721.4261.4331.823
Accounts Receivables 0000.211-0.1330.2080.02-0.0650.047-0.0190.1340.401-0.525-0.19975-750000000
Change In Inventory 00021.696-27.7896.0930000012.1-7.34912.9473.762-12.6010000000
Change In Accounts Payables -4.33.2050.102-5.374-1.2222.8021.41.9674.633-3.388-1.2232.433-0.636-0.056-0.8111.2832.352-1.707-2.3382.3470.1280.541-0.016
Other Working Capital -17.5159.6397.876-37.1320.3590.4095.9944.468-5.007-0.0583.4460.0460.0450.0560.130.3-3.1632.8072.897-2.7191.2980.8921.839
Other Non Cash Items 20.12711.69824.379-10.813-1.2-2.152-3.02-10.9293.6020.2-3.9140.8362135.4040.1530.0140.008-0.117-0.321-0.635-1.138-0.7220.056
Operating Cash Flow -75.083-65.833-50.323-89.188-75.397-68.601-67.13-57.079-66.145-57.093-49.173-39.707-53.199-28.1446.64-35.272-24.039-20.844-22.334-22.761-17.503-15.053-10.816
Investing Activities:
Investments In Property Plant And Equipment -0.227-0.011-1.78-0.118-0.59-1.503-1.915-2.316-2.095-1.857-2.794-0.88-1.736-0.379-0.476-0.064-0.433-0.414-1.02-0.598-2.387-1.873-3.144
Acquisitions Net 000-257.634-71.955-52.78-77.229144.62-29.28200-0.083-0.083-25.132000000000
Purchases Of Investments -265.135-119.634-190.784-136.815-84.752-66.16-97.815-327.641-55.833-24.255-127.69-327.032-7.394-26.919-619.32-126.358-68.994-15.494-55.609-88.98-89.537-3750
Sales Maturities Of Investments 139.2165.195203.095196.611156.707118.94175.044183.02185.11569.518.135.253078.498386.17550.00289.5103.556107125.47599180
Other Investing Activites 045.56112.311257.63471.95552.7877.229-144.6229.28245.245-109.59-291.78222.606-25.132-233.145-76.35620.50688.06251.39136.4959.4630.020
Investing Cash Flow -126.16245.5510.53159.67871.36551.27775.314-146.93627.18743.388-112.384-292.74520.78726.068-233.621-76.4220.07387.64850.37135.8977.076-358.853-3.144
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued -20.6611.54248.92220.9189.4582.081.297284.744285.8651.9960.883382.210.9021.1212.0550.056428.2420.3670.3510.4410.120.0230.029
Common Stock Repurchased 1.12900000000000000-2.4510000000
Dividends Paid 00000000000000000000000
Other Financing Activities 238.4211.54248.92219.4582.081.297-283.578285.8651.9960.8831.8020.9021.1212.0552.507-2.047-0.460.351-0.668-0.0040.6475.018
Financing Cash Flow 218.8891.54248.92221.9189.4582.081.2971.166285.8651.9960.883384.0120.9021.1212.0550.056426.195-0.0930.351-0.2270.1160.675.047
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000
Net Change In Cash 20.351-18.7419.13-7.5925.426-15.2449.481-202.849246.907-11.709-160.67451.56-31.51-0.951-184.926-111.636422.22966.71128.38812.909-10.311-373.236-8.913
Cash At End Of Period 154.476134.125152.866146.443154.035148.609163.853154.372357.221110.314122.023282.697231.137262.647263.598448.524560.16137.93171.2242.83229.92340.234413.47